"Thromboxane B2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A stable, physiologically active compound formed in vivo from the prostaglandin endoperoxides. It is important in the platelet-release reaction (release of ADP and serotonin).
Descriptor ID |
D013929
|
MeSH Number(s) |
D10.251.355.255.100.825.810 D10.251.355.310.166.971.810
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Thromboxane B2".
Below are MeSH descriptors whose meaning is more specific than "Thromboxane B2".
This graph shows the total number of publications written about "Thromboxane B2" by people in this website by year, and whether "Thromboxane B2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 1 | 2 |
1996 | 0 | 1 | 1 |
2001 | 1 | 2 | 3 |
2002 | 0 | 2 | 2 |
2003 | 2 | 2 | 4 |
2004 | 0 | 1 | 1 |
2006 | 0 | 1 | 1 |
2011 | 1 | 1 | 2 |
2013 | 0 | 1 | 1 |
2019 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Thromboxane B2" by people in Profiles.
-
Obesity and laboratory aspirin resistance in high-risk pregnant women treated with low-dose aspirin. Am J Obstet Gynecol. 2019 04; 220(4):385.e1-385.e6.
-
Inhibition of sphingosine kinase-2 in a murine model of lupus nephritis. PLoS One. 2013; 8(1):e53521.
-
Urinary thromboxane B2 and thromboxane receptors in bladder cancer: opportunity for detection and monitoring. Prostaglandins Other Lipid Mediat. 2011 Nov; 96(1-4):41-4.
-
Selective cyclooxygenase-2 inhibitor suppresses renal thromboxane production but not proliferative lesions in the MRL/lpr murine model of lupus nephritis. Am J Med Sci. 2011 Feb; 341(2):101-5.
-
The phosphatidylinositol 3 kinase pathway regulates tolerance to lipopolysaccharide and priming responses to Staphylococcus aureus and lipopolysaccharide. Shock. 2006 Jul; 26(1):31-6.
-
Staphylococcus aureus and lipopolysaccharide induce homologous tolerance but heterologous priming: role of interferon-gamma. Shock. 2004 Mar; 21(3):254-60.
-
Ceramide kinase mediates cytokine- and calcium ionophore-induced arachidonic acid release. J Biol Chem. 2003 Oct 03; 278(40):38206-13.
-
Peroxisome proliferator-activated receptor-gamma agonists modulate macrophage activation by gram-negative and gram-positive bacterial stimuli. Shock. 2003 Jul; 20(1):56-62.
-
A thromboxane A(2) system in the Atlantic stingray, Dasyatis sabina. Gen Comp Endocrinol. 2003 Feb 01; 130(2):157-64.
-
Genetic variation in cyclooxygenase 1: effects on response to aspirin. Clin Pharmacol Ther. 2003 Jan; 73(1):122-30.